Meeting NewsVideo

Servier’s oncology presence includes treatments for gastrointestinal cancers, hematologic malignancies

CHICAGO — Yann Orsi, head of global therapeutic area oncology at Servier Group, spoke with HemOnc Today about its philosophy and research efforts.

Servier — which participated in ASCO Annual Meeting for the first time since establishing a presence in the United States last year — comprises an international group that operates in 149 countries.

The company — operated by a nonprofit foundation — is commercializing five different treatments in oncology. These include therapies for metastatic colorectal cancer, pancreatic cancer, acute lymphoblastic leukemia and non-Hodgkin lymphoma.

CHICAGO — Yann Orsi, head of global therapeutic area oncology at Servier Group, spoke with HemOnc Today about its philosophy and research efforts.

Servier — which participated in ASCO Annual Meeting for the first time since establishing a presence in the United States last year — comprises an international group that operates in 149 countries.

The company — operated by a nonprofit foundation — is commercializing five different treatments in oncology. These include therapies for metastatic colorectal cancer, pancreatic cancer, acute lymphoblastic leukemia and non-Hodgkin lymphoma.

    See more from ASCO Annual Meeting